Company eyes large opportunity in treating liver cancer Rockland, MA-based BioSphere Medical reported this week that the Medical Device Department of the People’s Republic of China approved BioSphere’s Embosphere Microspheres for clinical […]
Breast Cancer Screening Co-Pay Could Hurt Insurers’ Bottom Line
A new study in The New England Journal of Medicine found that a modest insurance co-pay was enough to deter many older women from getting potentially life-saving mammograms. The study examined 366,475 […]
New Study Highlights Promising Gene-Based Predictor of Prostate Cancer Risk
Test to be commercialized by Proactive Genomics, LLC In the past few years, novel research tools have emerged which scientist to systematically and objectively evaluate genetic variants in the genome. These new […]
MelaFinding Its Way
Irvington-NY based Electro-Optical Sciences (EOS), developer of The MelaFind System, a handheld imaging device that detects melanomas at an early stage, announced last week that its pivotal trial is over two-thirds complete. […]
AngioDynamics Technology Not Responsible for Lung Tumor Treatment Deaths
In February 2003, the FDA’s General and Plastic Surgery Devices Advisory Committee met and discussed thermal ablation of lung tumors. Concerns were raised about the safety and adverse event reporting associated with […]
EDAP TMS’ Ablatherm Study Relevant to FDA Clinical Investigation
High Intensity Focused Ultrasound (HIFU) is competitive with currently accepted non-surgical standards of care, such as radiotherapy, but results in milder side effects, reveals the first long-term study of HIFU for the […]
Rockland Technimed: Tissue Viability Imaging
Early detection of ischemic injury, though difficult to achieve, is becoming increasingly critical to the proper utilization of new interventional procedures. Experts note that although Magnetic Resonance Angiography can evaluate vessel anatomy […]
[Video] Interview with Kathryn Tunstall, Chairman of NeoMatrix
Irvine, California-based NeoMatrix offers the HALO Breast Pap Test, a fully automated, noninvasive breast disease screening device designed for use in a primary care setting. HALO is FDA approved for the collection […]
